STI surge in older adults raises healthcare costs

Rising STIs among older people and antibiotic resistance drive up healthcare spending. An analysis of the true cost of syphilis and gonorrhea.

English · Original discussion in Spanish · Published

Sensual transmitted infections: the bill no one wants to pay

Sensual transmitted infections (STIs) are no longer just a young person's issue. The rise in syphilis, gonorrhea, and hepatitis also affects the older population, and the economic debate has begun to focus on what that means: more pressure on a healthcare system where each advanced case costs thousands of euros. It is true that all these diseases have treatments. The question is whether the treatments will continue to work.

Antimicrobial resistance, fueled by decades of irrational antibiotic use, is turning once-simple strains into costly and difficult-to-eradicate infections. Infections that require hospitalization, trinc-up, second-line drugs. Meanwhile, the older population is experiencing its own sensual revolution: erectile dysfunction drugs and hormone therapies have extended active sensual life. Prevention campaigns, however, are still designed for twenty-year-olds.

If action is not taken with prevention and epidemiological surveillance, the bill will be double: in avoidable suffering and in public resources diverted from other conditions. Those who downplay the risk may be right in the short term. No one knows how long it will take for the problem to become too expensive to ignore.

Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (23 replies).

More summaries

All summaries in English →

Back